Advertisement

Picture EBD Group BioPharm America 2016 BPA Boston September 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 6885 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 67 68 69  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Formycon–Deutsche Börse: investor conference, 201511 supply service Formycon AG presents at Deutsches Eigenkapitalforum 2015 2015-11-23
Genetrix (ES)–Deutsche Börse: investor conference, 201511 supply service Sygnis AG presents at Deutsches Eigenkapitalforum 2015 2015-11-23
MorphoSys–Deutsche Börse: investor conference, 201511 supply service MorphoSys AG presents at Deutsches Eigenkapitalforum 2015 2015-11-23
Neovacs–Deutsche Börse: investor conference, 201511 supply service Neovacs presents at Deutsches Eigenkapitalforum 2015 2015-11-23
ObsEva–MacDougall Biomedical Communications: public relations, 201511 service existent by MacDougall 2015-11-23
Paion–Deutsche Börse: investor conference, 201511 supply service Paion AG presents at Deutsches Eigenkapitalforum 2015 2015-11-23
Probiodrug–BIO Deutschland: partnering conference, 201511 supply service Probiodrug AG attends European Businesss Development 2015 in Antwerp 2015-11-23
Probiodrug–Deutsche Börse: investor conference, 201511 supply service Probiodrug AG presents at Deutsches Eigenkapitalforum 2015 2015-11-23
Sartorius–Deutsche Börse: investor conference, 201511 supply service Sartorius AG presents at Deutsches Eigenkapitalforum 2015 2015-11-23
Stratec–Deutsche Börse: investor conference, 201511 supply service Stratec Biomedical AG presents at Deutsches Eigenkapitalforum 2015 2015-11-23
Transgene–Deutsche Börse: investor conference, 201511 supply service Transgene SA presents at Deutsches Eigenkapitalforum 2015 2015-11-23
Vita 34–Deutsche Börse: investor conference, 201511 supply service Vita 34 AG presents at Deutsches Eigenkapitalforum 2015 2015-11-23
Merck (DE)–Univ Cape Town: malaria drug, 201511– collab research with UCT H3D to develop anti-malarial drug candidates using Merck compound library 2015-11-19
Affimed–Jefferies: investor conference, 201511 supply service Affimed NV presents at Jefferies 2015 Global Healthcare Conference London 2015-11-18
Evotec–Jefferies: investor conference, 201511 supply service Evotec AG presents at Jefferies 2015 Global Healthcare Conference London 2015-11-18
Greiner–Oncgnostics: cervical cancer test, 201511– distribution of GynTect test by Greiner Bio-One in DACH + FR + GB + Benelux 2015-11-18
Medigene–Jefferies: investor conference, 201511 supply service Medigene presents at Jefferies Global Healthcare Conference London 2015-11-18
Oncotest–Charles River: investment, 201511 acquisition of Oncotest GmbH for €34m in cash + €2m milestones 2015-11-18
Probiodrug–Jefferies: investor conference, 201511 supply service Probiodrug AG attends at Jefferies Global Healthcare Conference London 2015-11-18
Molecular Health–Hopp Group: investment, 201511 private financing round totalling €25m led by existing investor Dievini 2015-11-16
Molecular Health–SEVERAL: investment, 201511 private financing round €25m led by existing investor Dievini 2015-11-16
Greiner–Scienion: print/spotting technology, 201511 collab integrating sciFlexarrayer techn w Genspeed platform for rapid Dx tests 2015-11-13
Curetis–CMS: legal services, 201511 service CMS advisor for Curetis IPO at Euronext Amsterdam + Brussels 2015-11-11
Probiodrug–SEVERAL: investment, 201511 private placement €13.5m w 677k new shares at €20/share to Europ + US investors 2015-11-05
Probiodrug–Informa: partnering conference, 201511 supply service Probiodrug presents at BIO-Europe 2015 in Munich 2015-11-04
CureVac–Baillie Gifford: investment, 201511 private placement totalling €100m incl new + lead investor Baillie Gifford 2015-11-03
CureVac–Chartwave: investment, 201511 private placement totalling €100m incl new investor Chartwave Ltd 2015-11-03
CureVac–Coppel Group: investment, 201511 private placement totalling €100m incl new investor Coppel family 2015-11-03
CureVac–Elma Investments: investment, 201511 private placement totalling €100m incl new investor Elma Investments Ltd 2015-11-03
CureVac–Gates Foundation: investment, 201511 private placement totalling €100m incl existing investor Bill & Melinda Gates Foundation 2015-11-03
CureVac–Hopp Group: investment, 201511 private placement totalling €100m incl existing investor dievini Hopp Biotech Holding GmbH & Co KG 2015-11-03
CureVac–Rittershaus: legal services, 201511 supply legal advisor for €100m financing round 2015-11-03
CureVac–SEVERAL: investment, 201511 private placement €100m led by Baillie Gifford 2015-11-03
CureVac–Sigma Group: investment, 201511 private placement totalling €100m incl new investor Sigma Group 2015-11-03
Neovacs–Informa: partnering conference, 201511 supply service Neovacs presents at BIO-Europe 2015 in Munich 2015-11-03
Sanofi–BioNTech: cancer immunotherapy, 201511– collab + license agreement for mRNA-based therapeutics 2015-11-03
Erytech–Informa: partnering conference, 201511 supply service Erytech Pharma participates in BIO-Europe 2015 in Munich 2015-11-02
Lead Pharma–Akampion: public relations, 201511 service existent by Akampion 2015-11-02
Medigene–Informa: partnering conference, 201511 supply service Medigene participates in BIO-Europe 2015 in Munich 2015-11-02
Merck (DE)–Selvita: drug discovery services, 2013–2015 collab 2-year partnership in cancer metabolism 2015-11-02
Merck (DE)–Selvita: drug discovery services, 201511– collab €na 3-year r+d small-molecule cancer drugs 2015-11-02
BFCC project–EU (govt): grant, 201511– grant €3.6m for Baltic Fracture Competence Centre from Interreg Baltic Sea Region Programme 2015-11-01
BFCC project–Hamburg (govt): healthcare, 201511– Life Science Nord Management GmbH is lead partner in Baltic Fracture Competence Centre 2015-11-01
BioGenes–PERSON: investment, 201510 MBO €na from GUB Unternehmensbeteiligungen + VC Fonds Berlin by the two founders 2015-10-31
Co.don–SEVERAL: investment, 201510–201511 capital increase €5m with 2.5m new shares at €2/share w existing + new investors 2015-10-30
GeneWake–R-Biopharm: investment, 201510 acquisition of GeneWake GmbH which had filed for bankruptcy in February 2015 2015-10-29
High-Tech Gründerfonds–Donghai Securities: business services, 201510– collab service for accessing Chinese capital + markets 2015-10-29
BioLamina–Cevec: rec protein production technology, 201510– license €na to CAP Go technology for laminins for ex vivo cell culture therapies 2015-10-28
Cevec–iBET (PT): rec protein production, 201510 collab existent GenIbet is joint venture partner of Cevec 2015-10-28
Curetis–Stratec: investment, 201510 existent Stratec Biomedical AG is existing investor 2015-10-28
Biofrontera–SEVERAL: investment, 201510–201511 capital increase €3.64m net €3.1m with 1.92m new shares at €2/share 2015-10-27
Computomics–High-Tech Gründerfonds: investment, 201510 HTGF invests into Computomics GmbH 2015-10-27
Probiodrug–Sofinnova: partnering conference, 201510 supply service Probiodrug presents at Sofinnova Japan Biopharma Partnering Conference in Tokyo 2015-10-27
Neuway Pharma–SEVERAL: investment, 201510 financing round Series A Extension €3.15m led by Wellington Partners bringing Series A to €5.85m 2015-10-22
Neuway Pharma–Wellington Partners: investment, 201510 financing round Series A Extension totalling €3.15m incl €2m from Wellington Partners 2015-10-22
Beyond Batten Disease Foundation–Evotec: drug discovery services, 201510–201712 supply service €na assay developm + use for drug discovery 2015-10-20
Noxxon–SEVERAL: investment, 201510– intention to launch IPO of new shares at Euronext Amsterdam + Paris 2015-10-20
Probiodrug–BIO (US): investor conference, 201510 supply service Probiodrug presents at BIO Investor Forum in San Francisco 2015-10-20
Sigma-Aldrich–Honeywell: research chemicals, 201510–201512 acquisition of Sigma-Aldrich research chemicals business by Honewell 2015-10-20
Zellkraftwerk–Helmholtz: investment, 201510 Ascenion acquires equity position under license agreem with MHH for Switch-Antibodies technology 2015-10-20
Zellkraftwerk–MHH: Switch-Antibodies technology, 201510– license ww excl to Zellkraftwerk GmbH from MHH 2015-10-20
Univ Münster–Thermo Fisher: mass spectrometer, 201510 supply Q Exactive GC hybrid quadrupole-Orbitrap GC-MS/MS system to MEET Battery Research Center 2015-10-19
Curetis–SEVERAL: investment, 201510–201511 IPO €40m+€4.3m w 4m+431k new shares at €10/share at Euronext Amsterdam + Brussels 2015-10-14
Luxendo–EMBL: investment, 201510 financing round Series A totalling €6m co-led by EMBL Ventuers + LSP 2015-10-14
Luxendo–Life Sciences Partners: investment, 201510 financing round Series A totalling €6m co-led by EMBL Ventuers + LSP 2015-10-14
Luxendo–SEVERAL: investment, 201510 financing round Series A €6m co-led by EMBL Ventuers + LSP 2015-10-14
Zymeworks–Minapharm: GlymaxX technology, 201510– supply service cell line development for bispecific antibody production applying GlymaxX by ProBioGen 2015-10-14
Boehringer–Philogen: cancer immunotherapy, 201510– collab novel therapeutic concepts for treating AML 2015-10-12
Affimed–OTHER: investment, 201510 investment €19.2m purchase of 3.3m shares by existing shareholder 2015-10-09
NEO New Oncology–Akampion: public relations, 201510 service existent by Akampion 2015-10-09
NEO New Oncology–SEVERAL: investment, 201510 financing round €5m 2015-10-09
Glycotope–Octapharma: investment, 201510 acquisition of new shares by Octapharma as part of excl license deal 2015-10-08
Octapharma–Glycotope: protein expression technology, 201510– license ww excl to human coagulation factors based on GEX technology 2015-10-08
Merck (US)–Proteros: drug discovery services, 201510– collab €na upfront + research funding + $126m milestones + royalties r+d small mol cancer drug 2015-10-07
Nestlé–Lipotype: lipidomics research, 201510 collab existent use of Lipotype technology for lipid analysis in nutritional research NIHS 2015-10-07
Probiodrug–Rentschler: biological contract manufacturing, 201510– process developm + production of PBD-C06 for pre-clinical + clinical studies 2015-10-07
EMBL–IBM: software tools, 201510– supply EMBL deploys Aspera s/w for fast + reliable data transfer 2015-10-05
Affimed–Aeris Capital: investment, 201510 investment $21.8m for 3.3m shares by existing investor Aeris Capital 2015-10-01
Opti-Lab–Omnilab (DE): investment, 201510 acqu of additonal shares resulting in majority for Omnilab w sole minority owner now Sebastian Haselhun 2015-10-01
Tizona Therapeutics–Minapharm: GlymaxX technology, 201510– license + contract manufacturing agreem for use of GlymaxX for cancer antibody ProBioGen AG 2015-10-01
Infinity Pharmaceuticals–Max Planck: drug discovery services, 201509– collab in cancer using LDC network with MPG + Helmholtz 2015-09-29
JnJ–Protectimmun: asthma drug, 201509 collab research JnJ Innovation funding preclinical study at Imperial College Protectimmune lead candidate 2015-09-28
Beijing Clear Biotech–Curetis: Unyvero platform, 201509– distribution excl in Greater China of system + 2 cartridges by BCB 2015-09-25
Medigene–Baader Bank: investor conference, 201509 supply service Medigene presents at Baader Investment Conference 2015 in Munich 2015-09-22
Zedira–Cardiff Univ: drug discovery, 201509– collab research role of transglutaminase 6 in disease pathway of cerebellar ataxia 2015-09-22
Qiagen–PathoFinder: molecular diagnostics, –201509 collab developm + production of RespiFast RG Panel for Rotor-Gene Q MDx instrument 2015-09-21
Biametrics–SEVERAL: investment, 201509 financing round Series A €3.1m from LBBW Venture + MBG BW + KfW 2015-09-18
French Myopathy Association–Cevec: cell line technology, 201509– license €na to use CAP GT technology for lentivirus cell line developm to Généthon 2015-09-17
Nestlé–Lipid Therapeutics: gastrointestinal drug, 201609– license excl to develop + market LT-02 ww excl Europe + Australia to Nestlé Health Science 2015-09-16
IAVI–CureVac: mRNA technology, 201509– collab using RNActive technology to deliver HIV immunogens for developm of AIDS vaccines 2015-09-10
Lophius–SEVERAL: investment, 201509 financing round incl VRD GmbH + S-Refit + Wolf Biotech + Bayern Kapital + HTGF 2015-09-10
Venneos–High-Tech Gründerfonds: investment, 201509 seed financing round totalling €1m from HTGF + Max Planck + business angels + family offices 2015-09-10
Venneos–Max Planck: investment, 201509 seed financing round totalling €1m from HTGF + Max Planck + business angels + family offices 2015-09-10
Venneos–SEVERAL: investment, 201509 seed financing round €1m from HTGF + Max Planck + business angels + family offices 2015-09-10
Lophius–High-Tech Gründerfonds: investment, 201509 financing round incl VRD GmbH + S-Refit + Wolf Biotech + Bayern Kapital + HTGF 2015-09-09
Lumora–Erba Diagnostics Mannheim: investment, 201509 acquisition of Lumora Ltd renamed Erba Molecular Ltd 2015-09-07
Boehringer–Vectron Biosolutions: gene expression technology, 201509– license non-excl to Vectron technology for use w BI e. coli production system 2015-09-01
Labfolder–SEVERAL: investment, 201509 financing round € 7-digit led by Charité Biomedical Fund (CBF-1) 2015-09-01
Pfizer–Evotec: drug discovery services, 201509– collab + license agreem 4 years to develop anti-fibrotics 2015-09-01
Hisun Pharmaceutical–IMD Natural Solutions: drug discovery, 201508– collab using IMD natural product lead discovery platform incl €4m investment 2015-08-31
next pagenext page 1 2 3 4 ... 67 68 69  next pagenext page



Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x80px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2016 Frankfurt 120x240px Picture EBD Group BioPharm America 2016 BPA Boston September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px